As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Delayed PK data hampers clinical assessment
Delay in availability of Pharmacokinetic (PK) data from Bio-Analytics labs inhibits assessment of clinical pathology findings. Challenge: Pharmacokinetic Concentration (PC)... read more
PointCross announces full complement release of eDataValidator
July 20 2022 – PointCross Life Sciences has released the full complement of its eDataValidator™ (eDV) for validating SDTM, ADaM, SEND and... read more
Unlocking Insights: Cross-Study Analysis of SEND Datasets with Xbiom™
For those who couldn't join us live, we're excited to share the recording of our third SEND webinar! This... read more
Validation for Clinical SDTM, ADaM, and Nonclinical SEND Data
Introduction In the fast-paced world of life sciences validation software, accurate and compliant data validation is crucial for successful... read more